ZA927398B - Combination containing growth factors and polyelectrolytes. - Google Patents
Combination containing growth factors and polyelectrolytes.Info
- Publication number
- ZA927398B ZA927398B ZA927398A ZA927398A ZA927398B ZA 927398 B ZA927398 B ZA 927398B ZA 927398 A ZA927398 A ZA 927398A ZA 927398 A ZA927398 A ZA 927398A ZA 927398 B ZA927398 B ZA 927398B
- Authority
- ZA
- South Africa
- Prior art keywords
- polyelectrolytes
- growth factors
- combination containing
- containing growth
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4132005A DE4132005A1 (de) | 1991-09-26 | 1991-09-26 | Kombination enthaltend wachstumsfaktoren und polyelektrolyte |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA927398B true ZA927398B (en) | 1993-04-02 |
Family
ID=6441511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA927398A ZA927398B (en) | 1991-09-26 | 1992-09-25 | Combination containing growth factors and polyelectrolytes. |
Country Status (16)
Country | Link |
---|---|
US (2) | US5885960A (xx) |
EP (1) | EP0534310A1 (xx) |
JP (1) | JPH05213766A (xx) |
KR (1) | KR930005633A (xx) |
AU (1) | AU2525092A (xx) |
CA (1) | CA2079042A1 (xx) |
CZ (1) | CZ281452B6 (xx) |
DE (1) | DE4132005A1 (xx) |
HU (1) | HUT64479A (xx) |
MX (1) | MX9205438A (xx) |
NO (1) | NO923746L (xx) |
PL (1) | PL296034A2 (xx) |
RU (1) | RU2080872C1 (xx) |
SK (1) | SK265692A3 (xx) |
TW (1) | TW273512B (xx) |
ZA (1) | ZA927398B (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221840B1 (en) * | 1991-02-14 | 2001-04-24 | The General Hospital Corporation | Intestinal trefoil proteins |
DE4132005A1 (de) * | 1991-09-26 | 1993-04-01 | Merck Patent Gmbh | Kombination enthaltend wachstumsfaktoren und polyelektrolyte |
US6525018B1 (en) | 1999-05-17 | 2003-02-25 | The General Hospital Corp. | Treating eye disorders using intestinal trefoil proteins |
CN1194369C (zh) | 1999-10-22 | 2005-03-23 | 松下电器产业株式会社 | 阴极射线管和使用该阴极射线管的图像显示装置 |
DE10022656B4 (de) * | 2000-04-28 | 2006-07-06 | Infineon Technologies Ag | Verfahren zum Entfernen von Strukturen |
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
TW527722B (en) * | 2002-03-20 | 2003-04-11 | Macronix Int Co Ltd | Non-volatile memory device and fabrication method thereof |
SG176314A1 (en) * | 2002-12-31 | 2011-12-29 | Altus Pharmaceuticals Inc | Human growth hormone crystals and methods for preparing them |
NZ571243A (en) * | 2002-12-31 | 2010-04-30 | Altus Pharmaceuticals Inc | Complexes of protein crystals and ionic polymers comprising human growth hormone and protamine |
JP2009521486A (ja) * | 2005-12-23 | 2009-06-04 | アルタス ファーマシューティカルズ インコーポレイテッド | ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法 |
EP2262474B1 (en) * | 2008-01-30 | 2019-07-03 | Imbed Biosciences, Inc. | Methods and compositions for wound healing |
BRPI0801422B8 (pt) * | 2008-03-26 | 2021-05-25 | Fund Sao Francisco Xavier | composição e método para inibição da severidade das aderências pós-cirúrgicas |
WO2011100425A2 (en) * | 2010-02-10 | 2011-08-18 | Wound Engineering Llc | Methods and compositions for wound healing |
JP5767314B2 (ja) * | 2010-04-16 | 2015-08-19 | ソーク インスティチュート フォー バイオロジカル スタディーズ | Fgfを用いて代謝障害を処置するための方法 |
WO2015061361A1 (en) | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Mutated fibroblast growth factor (fgf) 1 and methods of use |
WO2015061331A1 (en) | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use |
JP2018535964A (ja) | 2015-10-30 | 2018-12-06 | ソーク インスティテュート フォー バイオロジカル スタディーズ | 線維芽細胞増殖因子(fgf)1アナログによるステロイド誘導性高血糖の処置 |
EP3490622B1 (en) | 2016-07-29 | 2023-09-06 | Imbed Biosciences, Inc. | Methods and compositions for wound healing |
US11542309B2 (en) | 2019-07-31 | 2023-01-03 | Salk Institute For Biological Studies | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose |
RU2734819C1 (ru) * | 2019-12-12 | 2020-10-23 | Общество с ограниченной ответственностью "ИНТЭКОС" (ООО "ИНТЭКОС") | Композиция для лечения ран и ожогов (варианты) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783412A (en) * | 1983-07-05 | 1988-11-08 | Chiron Corporation | Hybrid DNA synthesis of epidermal growth factor |
US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
JPS61253065A (ja) * | 1985-05-02 | 1986-11-10 | 片倉チツカリン株式会社 | キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法 |
EP0248819B2 (en) * | 1985-09-12 | 2000-08-30 | Scios Inc. | Recombinant fibroblast growth factors |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
DE4132005A1 (de) * | 1991-09-26 | 1993-04-01 | Merck Patent Gmbh | Kombination enthaltend wachstumsfaktoren und polyelektrolyte |
-
1991
- 1991-09-26 DE DE4132005A patent/DE4132005A1/de not_active Withdrawn
-
1992
- 1992-08-27 CZ CS922656A patent/CZ281452B6/cs unknown
- 1992-08-27 SK SK2656-92A patent/SK265692A3/sk unknown
- 1992-09-17 EP EP92115887A patent/EP0534310A1/de not_active Ceased
- 1992-09-21 AU AU25250/92A patent/AU2525092A/en not_active Abandoned
- 1992-09-24 MX MX9205438A patent/MX9205438A/es unknown
- 1992-09-24 PL PL29603492A patent/PL296034A2/xx unknown
- 1992-09-24 TW TW081107566A patent/TW273512B/zh active
- 1992-09-24 KR KR1019920017373A patent/KR930005633A/ko not_active Application Discontinuation
- 1992-09-24 CA CA002079042A patent/CA2079042A1/en not_active Abandoned
- 1992-09-25 RU SU925052705A patent/RU2080872C1/ru active
- 1992-09-25 HU HU9203079A patent/HUT64479A/hu unknown
- 1992-09-25 ZA ZA927398A patent/ZA927398B/xx unknown
- 1992-09-25 JP JP4296268A patent/JPH05213766A/ja active Pending
- 1992-09-25 NO NO92923746A patent/NO923746L/no unknown
-
1994
- 1994-10-28 US US08/330,619 patent/US5885960A/en not_active Expired - Fee Related
-
1998
- 1998-11-24 US US09/198,533 patent/US6147053A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL296034A2 (en) | 1993-07-12 |
JPH05213766A (ja) | 1993-08-24 |
CA2079042A1 (en) | 1993-03-27 |
NO923746D0 (no) | 1992-09-25 |
NO923746L (no) | 1993-03-29 |
CZ281452B6 (cs) | 1996-10-16 |
US5885960A (en) | 1999-03-23 |
SK265692A3 (en) | 1994-06-08 |
US6147053A (en) | 2000-11-14 |
CZ265692A3 (en) | 1993-04-14 |
MX9205438A (es) | 1993-03-01 |
HUT64479A (en) | 1994-01-28 |
EP0534310A1 (de) | 1993-03-31 |
TW273512B (xx) | 1996-04-01 |
RU2080872C1 (ru) | 1997-06-10 |
KR930005633A (ko) | 1993-04-20 |
HU9203079D0 (en) | 1992-12-28 |
AU2525092A (en) | 1993-04-01 |
DE4132005A1 (de) | 1993-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA927398B (en) | Combination containing growth factors and polyelectrolytes. | |
GR3024174T3 (en) | Anchorage. | |
HU9601504D0 (en) | Infuser | |
ZA926482B (en) | Cyanophenylpyrroles. | |
ZA929958B (en) | Insert and insert support bar. | |
ZA927792B (en) | Anti-alpha6-integrin-antibodies. | |
EP0601405A3 (de) | Polymere Borosilazane und Alumosilazana, Verfahren zu ihrer Herstellung sowie deren Verwendung. | |
ZA929294B (en) | Syringe. | |
DE69205795D1 (en) | Mesoprotheseunterlage. | |
ZA931481B (en) | Implants. | |
EP0572573A4 (en) | Thyroid-derived chondrocyte-stimulating factor. | |
GB9125820D0 (en) | Blade retainer | |
DE69203865D1 (en) | Thermo-transferdrucksystem. | |
EP0586848A3 (de) | Implantat. | |
ZA929331B (en) | Quinolylmethoxyphenyl-acetamides. | |
ZA929820B (en) | Heisswinderschieber. | |
GB2259313B (en) | Glasshouse and gutters therefor | |
EP0523005A3 (en) | Disazodyes with cycloalkylester or cycloalkylamide rests | |
HU9203085D0 (en) | Growth enhancing device | |
ZA921865B (en) | Isoxazole- and isothiazole-5-carboxamides. | |
ZA926946B (en) | Mower. | |
DE59200703D1 (en) | Polyketomethinfarbstoffe. | |
ZA925447B (en) | Novel microorganism and insecticide. | |
PH30999A (en) | Benzoquinoxalines. | |
ZA932458B (en) | Naphtoquinones and their use. |